Saint Luke's Newsroom
Apr. 16, 2024

Double the Teamwork
Kelly Anspaugh received both a heart and kidney transplant at Saint Luke's.
Apr. 12, 2024

Express Yourself Camp: Summer Grief Camp for Children Struggling with Loss
Express Yourself Camp is designed for kids ages 5 – 14 who have experienced a loss or change.
Apr. 12, 2024

Health News You Can Use: Advances in Transplant & Organ Donation
Dr. Matthew Wilkinson, a transplant surgeon at Saint Luke’s talks about the advances in organ donation and the importance of living organ donation.
Apr. 11, 2024

AARP: 10 Types of Exercise That Can Help You Live Longer
AARP talked to Dr. James O'Keefe about different types of exercise that can help improve longevity.
Apr. 10, 2024

U.S. News & World Report: Wegovy Helps Those With Both Diabetes, Heart Failure: Study
For people struggling with both diabetes and a common type of heart failure, the weight-loss drug Wegovy may do more for their health than help them shed pounds, new research suggests.
Apr. 9, 2024

Trading Days for Years
Before his heart transplant, Robert Johnson had a hard time even cutting his grass. Now, after receiving a heart transplant at Saint Luke's Mid America Heart Institute, he is back to enjoying physical activities, like golf.
Apr. 8, 2024

MEDIA COVERAGE: Obesity Medication Proves Effective in Treating Patients with Obesity-Related Heart Failure and Type 2 Diabetes
A new study led by Dr. Mikhail Kosiborod found patients with obesity-related heart failure and type 2 diabetes had significant improvement in symptoms and physical limitations when taking semaglutide.
Apr. 8, 2024

CNN: Weight-Loss Drug Wegovy Offers Benefits for People with Diabetes and Common Form of Heart Failure, Study Finds
The popular weight loss drug Wegovy seems to provide more health benefits for people who have diabetes and a common kind of heart failure than just helping take off the pounds, according to the results from the STEP HFpEF DM trial.
Apr. 8, 2024

Good Morning America: New Report on the Effect of Weight Loss Drugs on Heart Disease
A new study led by Dr. Mikhail Kosiborod found patients with obesity-related heart failure and diabetes had a significant improvement in symptoms when taking semaglutide.